TOKYO, Dec 20 (Bernama-AsiaNet) -- AGC Asahi Glass ("AGC"), a
world-leading manufacturer of glass, chemicals and high-tech materials,
announced on December 20 that it has entered into an agreement to
acquire 100% of the shares in CMC Biologics ("CMC"), a world-leading
biologics active pharmaceutical ingredient ("API") manufacturer with
major investors including Monitor Clipper Partners and European Equity
Partners, for the purchase price of approximately 60 billion Japanese
yen. The agreement remains subject to approval from the relevant
antitrust authorities, and the acquisition is expected to be completed
in January 2017.
http://mrem.bernama.com/viewsm.php?idm=28168
No comments:
Post a Comment